Christine Bestvina to Antineoplastic Agents
This is a "connection" page, showing publications Christine Bestvina has written about Antineoplastic Agents.
Connection Strength
0.789
-
Targeted Toxicities: Protocols for Monitoring the Adverse Events of Targeted Therapies Used in the Treatment of Non-Small Cell Lung Cancer. Int J Mol Sci. 2023 May 29; 24(11).
Score: 0.394
-
Patient-oncologist cost communication, financial distress, and medication adherence. J Oncol Pract. 2014 May; 10(3):162-7.
Score: 0.210
-
Severity of COVID-19 in patients with lung cancer: evidence and challenges. J Immunother Cancer. 2021 03; 9(3).
Score: 0.084
-
Anaplastic Lymphoma Kinase Mutation-Positive Non-Small Cell Lung Cancer. Thorac Surg Clin. 2020 May; 30(2):137-146.
Score: 0.079
-
Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice. Clin Cancer Res. 2022 03 15; 28(6):1117-1126.
Score: 0.023